Napsin-A and AMACR are superior to HNF-1β in distinguishing between mesonephric carcinomas and clear cell carcinomas of the gynecologic tract Journal Article
| Authors: | Pors, J.; Segura, S.; Cheng, A.; Ji, J. X.; Tessier-Cloutier, B.; Cochrane, D.; Fix, D. J.; Park, K.; Gilks, B.; Hoang, L. |
| Article Title: | Napsin-A and AMACR are superior to HNF-1β in distinguishing between mesonephric carcinomas and clear cell carcinomas of the gynecologic tract |
| Abstract: | Mesonephric carcinoma is a rare gynecologic neoplasm commonly mistaken for clear cell carcinoma, because of their overlapping morphologic features. Both tumors are negative for estrogen receptor and p16, magnifying this diagnostic dilemma. Recently, hepatocyte nuclear factor-1 beta (HNF-1 beta), a marker for clear cell carcinoma, has also been shown to be positive in mesonephric carcinomas. Other more recent markers for clear cell carcinoma, however, such as Napsin-A and alpha-methylacyl-CoA racemase (AMACR), have not yet been studied in mesonephric carcinomas. Here we examine HNF-1 beta, AMACR, and Napsin-A immunohistochemistry in 18 mesonephric and 55 endometrial/cervical clear cell carcinomas. HNF-1 beta was considered positive if nuclear staining was present in >= 70% of cells and at least moderate intensity; for Napsin-A and AMACR, any cytoplasmic staining was considered positive (>= 1%).H-scores were determined by multiplying the intensity score by proportion score. HNF-1 beta was positive in a substantial portion of mesonephric carcinomas (9/18, 50%;H-score 98) and clear cell carcinomas (34/55, 62%;H-score 163) and did not distinguish between the 2 entities (specificity, 50%;P-value ofH-score=0.08). Napsin-A and AMACR expression was significantly higher in clear cell [43/55 (78%) and 41/55 (75%), respectively] than mesonephric carcinomas [4/18 (22%) and 4/18 (22%) respectively], and helpful in this differential (specificity: 78% and 78%;P<0.05 for both). When Napsin-A and AMACR staining were seen in mesonephric carcinomas, staining was focal (<= 5%), whereas staining in clear cell carcinomas was patchy/diffuse. In summary, Napsin-A and AMACR are helpful in distinguishing mesonephric carcinomas from clear cell carcinomas of the female genital tract, but HNF-1 beta is not. |
| Keywords: | neoplasms; vagina; utility; clear cell carcinoma; amacr; uterine cervix; expression; marker; hnf-1 beta; adenocarcinomas; ovarian; immunohistochemical analysis; diagnostic; mesonephric carcinoma; napsin-a; racemase p504s |
| Journal Title: | Applied Immunohistochemistry & Molecular Morphology |
| Volume: | 28 |
| Issue: | 8 |
| ISSN: | 1541-2016 |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2020-09-01 |
| Start Page: | 593 |
| End Page: | 601 |
| Language: | English |
| ACCESSION: | WOS:000576510300006 |
| DOI: | 10.1097/pai.0000000000000801 |
| PROVIDER: | wos |
| PMCID: | PMC6987010 |
| PUBMED: | 31361605 |
| Notes: | Article -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work